The loan is expected to be funded and the equity investment is expected to close on Thursday, subject to completion of customary conditions.
The platform, Elevage, complements therapeutics backer Enavate, launched a year ago.
The financing round was led by General Catalyst and seeks to boost the company’s precision immunomodulators and oncology medicines.
The deal highlights ongoing interest in the influential point-of-care market.
MM+M is proud to announce the fourth annual Pinnacle Awards program, which celebrates the medical marketing industry’s most venerable marketers, strategists and creators.
Get the most out of
Register for free and enjoy unlimited access to:
